| [1] |
GENG Hongjiao, WANG Lianxin, XIE Yanming.
Pharmacovigilance of Chinese Medicine in Medical Institutions
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(6): 552-555.
|
| [2] |
SA Rina, ZHANG Bing, LIN Zhijian, WANG Xiaofang, ZHANG Xiaomeng.
Pharmacovigilance of Traditional Chinese Medicine in Pharmaceutical Care in Medical Institutions
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(5): 422-426.
|
| [3] |
HUANG Yuan, WANG Chenggang, WU Shifu, WANG Ling, TIAN Yuejie, WU Chen, WANG Xiaojun.
Drug Abuse Monitoring Models in Medical Institutions in China
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(9): 607-612.
|
| [4] |
FENG Yanan, LIU Xinxin, LI Yonghui, WANG Fang, GUO Ruifeng.
Challenges to Pharmacovigilance by Medical Institutions under the New Drug Administration Law
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(9): 572-573.
|
| [5] |
SHI Bing-juan.
Thinking on Improving and Guaranteeing the Quality of Traditional Chinese Medicine Preparations in Medical Institutions
[J]. Chinese Journal of Pharmacovigilance, 2018, 15(5): 276-279.
|
| [6] |
ZHAO Xia, LENG Meiling, WANG Peng, LI Xinling, CAO Lujuan, TIAN Chunhua, LIU Cuili.
Research on Current Status and Countermeasures of Information Collection on Adverse Drug Reactions by Drug Manufacturers from Medical Institutions in China
[J]. Chinese Journal of Pharmacovigilance, 2018, 15(11): 652-657.
|
| [7] |
LI Ang, ZHANG Bing, ZHANG Xiao-meng, SUN Xiao-xia, YANG Xue, LI Fan.
Investigation on the Situation of Cognition and Reporting of Adverse Drug Reactions in 1 109 Basic Medical Institutions
[J]. Chinese Journal of Pharmacovigilance, 2017, 14(5): 289-294.
|
| [8] |
TIAN Chun-hua .
Thinking to Promote Adverse Drug Reaction Monitoring Work of Medical Institutions
[J]. Chinese Journal of Pharmacovigilance, 2016, 13(5): 272-274.
|
| [9] |
LIU Cui-li, TIAN Chun-hua, FENG Hong-yun.
How Medical Institutions to Do Adverse Drug Reaction Monitoring Well
[J]. Chinese Journal of Pharmacovigilance, 2012, 9(4): 224-226.
|
| [10] |
GENG Kui-kui, LIU Sheng, SHEN Ai-zong.
The Exploration of Pharmacovigilance Based on the Hospital Information System
[J]. Chinese Journal of Pharmacovigilance, 2012, 9(2): 77-80.
|
| [11] |
ZHAO Huai-quan.
The Understanding and Discussion about Conducting Prescription Reviews in Medical Institutions
[J]. Chinese Journal of Pharmacovigilance, 2011, 8(8): 477-479.
|
| [12] |
WANG Wei-wei, ZHEN Jian-cun, SHI Lu-wen.
Build Early-warning System for the Safety of Drug Using in Medical Institutions
[J]. Chinese Journal of Pharmacovigilance, 2011, 8(8): 474-476.
|
| [13] |
YIN Ai-qun, MOU Wei-wei.
The Thought of Primary-level Organizations Junior Medical Device Adverse Event Monitoring
[J]. Chinese Journal of Pharmacovigilance, 2011, 8(5): 291-293.
|
| [14] |
LI Pan-hai, FENG Qiao-qiao, TIAN Yue-jie, HUANG Lin.
The Pratice and Thought of Medical Device Adverse Event Monitoring in Shandong Province
[J]. Chinese Journal of Pharmacovigilance, 2011, 8(3): 168-170.
|
